
Stryker fell 8.3% from $355.02 to $325.73, behind the S&P 500's +10.5%. Its worst day was Sep 8 (−8.8%), and its low came Sep 24 at $269.75.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $4.47 beat the $4.39 estimate on $7.2B revenue (est. $7.1B); FY EPS guidance of $14.90–$15.10 against the $14.96 consensus.
+4.3% · S&P 500 −0.3%
Stryker closed at its highest level of the year, 9.1% above where the year started.
+0.4% · S&P 500 −0.5%
EPS of $2.60 missed the $2.98 estimate on $6.0B revenue (est. $6.3B); FY EPS guidance of $14.90–$15.10 against the $14.95 consensus.
−6.5% · S&P 500 +0.3%
Stryker shares rose 5.3%, while the S&P 500 fell 0.7%.
+5.3% · S&P 500 −0.7%
Stryker shares fell 6.1%, while the S&P 500 rose 0.4%.
−6.1% · S&P 500 +0.4%
EPS of $3.69 beat the $3.49 estimate on $6.6B revenue (est. $6.6B); FY EPS guidance of $14.95–$15.10 against the $14.98 consensus.
−6.4% · S&P 500 +0.7%
Stryker shares fell 8.8%, while the S&P 500 fell 0.5%.
−8.8%, the year's worst day · S&P 500 −0.5%
Stryker closed at its lowest level of the year, 24.0% below where the year started.
−1.3% · S&P 500 −0.1%
EPS of $3.52 missed the $3.55 estimate on $6.5B revenue (est. $6.6B); FY EPS guidance of $14.80–$14.90 against the $14.95 consensus.
−6.4% · S&P 500 −1.8%
Where it ended: a close of $325.73 on Nov 9, 2026. Up next: Q4 2026 earnings on Jan 28, 2027 (EPS est. $5.02, revenue est. $7.7B).